ImClone Systems Inc (formerly IMCL)

[yaya704]

THANKS FOR THE RESPONSE. THE CLINICAL TRIALS WEBSITE STATES THAT BOTH PFIZER'S PHASE III STUDIES WITH THIS COMPOUND ARE STILL NOT FULLY ENROLLED. SO THAT GIVES ERBY AN EDGE WITH TIMING.

But how dew would you rate the efficacy of the pfizer compound in your HO.

Also in clinicaltrials.com one of imclone's studies with erbitux in the nsclc setting has a completion date of Dec. 2006. Could that still be accurate? thanks